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Abstract
Human plasminogen activator inhibitor type 1 (PAI-1) is an important serpin that plays a
role in the delicate balance between blood clot formation and fibrinolysis. Elevated PAI-1 levels
correlate with many diseased states such as diabetes, heart disease, and arthrosclerosis. PAI-1
functions to regulate plasminogen activation by inhibiting tissue-type and urokinase-type
plasminogen activators, which are serine proteases that cleave the zymogen form to produce
active plasmin. Its reactive center loop (RCL) binds the active sites of the target protease and
inactivates its enzymatic function. From immobilized metal affinity chromatography, it was
known that recombinant PAI-1 binds metals. This is relevant because metals have been
demonstrated to play roles in inflammatory response, tumor progression, diabetes and other
diseased states. Previous work has shown the effects of alkaline earth metals and transition
metals in the absence and presence of cofactor Vitronectin. We are currently exploring the use
of a lanthanide called terbium (Tb) that has been used with calcium binding proteins to accept
energy transferred from neighboring Tryptophan (Trp) residues. Native PAI-1 has four Trp
residues located at positions 86, 139, 175, and 262 in the functional protein sequence. Previous
investigation has shown the importance of the Trp side chains in kinetic stability of active PAI-1
and has shown that the high quantum yield of W262 gives the greatest contribution to PAI-1
fluorescence. Studies were conducted making steady state fluorescence measurements pertaining
to both L-Trp and wild-type/mutant PAI-1 experimentation using Trp light emission as a donor
for excitation of Tb as a Förster resonance energy transfer (FRET) acceptor in effort to obtain
donor-acceptor interdistance information. The increase of fluorescence emission at 544 nm
suggests that the metal and protein are indeed binding, and signal differences among the four Trp
sites, of which the brightest W262 site is highlighted in this work, will be used to elucidate the
approximate location of the transition metal binding site.
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Introduction
Human plasminogen activator inhibitor type 1 (PAI-1) is a serine protease inhibitor, or
serpin, that plays an important role in hemostasis, the delicate balance between blood clot
formation and fibrinolysis. PAI-1 enters the circulation by release from platelets, hepatocytes,
and adipocytes as well as other kinds of cells. Diseased states like arthrosclerosis and severe
sepsis exhibit marked inflammation with a dramatic increase in plasma concentrations of PAI-1,
and there is positive correlation between high levels of PAI-1 and invasiveness of certain types
of cancer.1 The PAI-1 serpin is comprised of 379 amino acids to produce a molecular weight of
43 kilodaltons (kDa) in its recombinant form, or approximately 50 kDa in its glycosylated native
form. This plasma glycoprotein regulates plasminogen activation by inhibiting tissue-type and
urokinase-type serine proteases, through presentation of a solvent-exposed pseudosubstrate loop
that effectively traps its bait protein. This reactive
center loop (RCL) of PAI-1 initiates the suicidal
behavior of the serpin as it binds the active site of
the target protease, effectively inactivating the
enzymatic function of the protease to generate
active plasmin by cleaving plasminogen. This
serpin

is

considered

metastable,

as

PAI-1

spontaneously transitions from an active to a latent
Figure 1: The transition of PAI-1 from
active to latent conformation.

conformation (Fig. 1) when the RCL inserts as a
beta strand into the central beta sheet. The RCL’s

mobility drives the conformational transitions. The activity of PAI-1 is typically measured by its
ability to inhibit its target protease tPA over time. As PAI-1 transitions to the latent confirmation,
there is less inhibition of target proteases and thus greater activity of tPA. The half-life of active
PAI-1 under physiological conditions (pH 7.4 and 37°C) is about 1-2 hours. When associated
with cofactor extracellular matrix protein vitronectin (VN) there is roughly a 50% increase in
half-life.
PAI-1 and VN exhibit low nanomolar affinity for complex formation (Fig. 2), and are
both found in circulation and the extracellular matrix. Aside from stabilizing the active PAI-1
3
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conformation by binding at its Somatomedin B
(SMB) interface and across an extended binding
interface,2 VN appears to localize the complex
to sites where inhibition of plasminogen
activation is needed, such as the fibrin matrix of
nascent blood clots. These proteins reside in the
plasma and extracellular space where they
function to inhibit fibrinolysis or extracellular
Figure 2: PAI-1 and VN complex

proteolysis, control cell adhesion and migration,

and assist in inflammatory response.
From immobilized metal affinity chromatography (IMAC) purification it was known that
recombinant PAI-1 binds metals, and the role of metals in PAI-1 is relevant because metals have
been demonstrated to play a role in the severity of inflammatory response, tumor progression,
diabetes, atherosclerosis, and neurological disease. According to the Protein Data Bank (PDB),
about 40% of proteins contain metal cofactors that serve structural and/or functional capacities.
Previous work in the Peterson Laboratory examined the effect of both alkaline earth metals (Mg,
Ca, Mn) and some transition metals (Fe, Co, Ni, Cu) on the stability of PAI-1 in the absence and
presence of cofactor VN.3 Metals were classified as oxygen seeking versus nitrogen/sulfur
seeking. This facilitated division into Type I alkaline earth metals which tend to form ionic
bonds and Type II transition metals which tend to
have partially covalent bond character. As illustrated
in Fig. 3, Type I metals (Mg, Ca, Mn) promoted a 1020 percent increase in PAI-1 stability, but no
additional stabilization when PAI-1 was complexed
with VN. In contrast, Type II (Cu, Ni, Co) metals had
a dramatic destabilizing effect on PAI-1 alone and a
stabilizing effect on the PAI-1: VN complex. For
example, nickel produced a 40-fold change in the
Figure 3: PAI-1 half-life in presence of
metals (taken from [2]: Thompson et al,
2011).

half-life of PAI-1 when assayed in the absence and
presence of VN.
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This investigation also established binding affinities of PAI-1 for the Type II metals
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using kinetic approach-to-equilibrium measurements of intrinsic tryptophan (Trp or W)
fluorescence shifts upon metal binding to PAI-1, which contains four Trp residues. These
included a first exponential corresponding to the metal-binding event, along with two more
exponentials thought to represent ensuing
conformational change of the metal-bound
protein. However, more recent work in the
Peterson Lab revealed that some of the Type II
metals interact directly with tryptophan (L-Trp)
in its free amino acid form (Fig. 4), resulting in
quenched fluorescence of the indole side chain.
The study now includes zinc, which competes
Figure 4: Some Type II metals quench
intrinsic Trp fluorescence.

with the interfering metals to restore quenched
L-Trp fluorescence. This post-transition metal

also causes rapid destabilization of active PAI-1, consistent with results from copper, the highest
affinity ligand among the Type II metals tested. Due to the low solubility of zinc, glycine has
been employed as a bioavailable chelator to assist dissolution. The presence of this additional
component creates uncertainty for actual free metal calculations and produces some fluorescence
measurement artifacts. Therefore, we are currently exploring the use of an optically active
lanthanide called terbium (Tb) that has historically been used with calcium binding proteins to
accept energy transferred from neighboring Trp residues using excitation light (295 nm) outside
the Tyr range and exclusive to the Trp range.5 This phenomenon is called Förster resonance
energy transfer (FRET), and if pilot studies with wild-type PAI-1 protein prove fruitful, then we
will expand our work with Tb to include the four mutant PAI-1 proteins that each contain only a
single Trp residue in effort to determine their individual proximities to the putative metal binding
site.
Native PAI-1 has four Trp residues located at positions 86, 139, 175, and 262 (Fig. 5).
Based on work by another group,6 the Peterson Lab has generated mutant PAI-1 proteins that
contain a single Trp site, wherein the other three residues are conservatively mutated to
phenylalanine (Phe or F). Phe was chosen to replace Trp because both are aromatic, and the
remaining aromatic residue, tyrosine (Tyr or Y), could interfere with fluorescence measurements
5
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despite

using

excitation

wavelength

of

295

nm.

Their

investigation showed the importance of the Trp side chains in
kinetic stability of active PAI-1 and showed that the high quantum
yield of W262 gives the greatest contribution to PAI-1
fluorescence. In the wild-type protein, fluorescence of this residue
is likely quenched by energy transfer to residue 175, as its overall
signal is lower than that of the “W262-Only” (W86-139-175F)
mutant. In general, the three W262F mutants (W86-Only, W139Only, and W175-Only) have lower quantum yields relative to
Figure 5: Trp sites in PAI-1
(structure image taken
from Verheyden et al,

wild-type PAI-1. Compared to wild-type PAI-1, all the triple
mutants containing W262F have ~20 min half-lives, while the
W262-Only mutant has 5 hour half-life reminiscent of the W175F

mutant.7 Manipulation of the W175 site profoundly influences RCL movement, including the
insertion of the N-terminal portion of the RCL into beta-sheet A during latency transition.
Spectral isolation of the individual Trp sites should allow us to gain perspective on the
metal binding conformational changes reported by each location. Therefore, studies were
conducted on four Trp mutants, with an emphasis on investigation of the W262-Only mutant,
using Tb as a FRET acceptor for selectively excited Trp fluorescence emissions.

Materials and Methods
These experiments focused on the interaction of PAI-1 with Terbium metal. To facilitate
the experiments, mutant strains of PAI-1 isolating 86, 139, 175, and 262 were needed. E. coli
Rosetta 2 (DE3) pLysS cells (Novagen) were used in this study because they have been
optimized for recombinant protein expression and have a quick doubling time of 45 minutes.
Competent cells were stored in CaCl2 solution inside the -80°C freezer. The standard
transformation reaction required 20 µL cells. Cells were removed from freezer and allowed to
thaw while immersed in ice for a few minutes. Visual examination was used to make sure they
had thawed, and tubes were finger-tapped to resuspend cells. Plasmid DNA amounting to 100
nanograms was added to 50 µL of the competent cell tubes, and the tubes were allowed to sit on
ice for 30 minutes. To trap the plasmids inside the cells, the tubes were heated for 30 to 90
seconds at 42°C in a water bath to activate housekeeping genes. This is known as the heat shock
6
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step. Then the tubes were cooled on ice for another two minutes. Then 500 µL of super optimal
broth with catabolite repression (SOC) media was added to each tube. This was followed by
growth in optimal conditions (37°C and shaking at 250 rpm) for two hours. Tubes were then
centrifuged for five minutes at 14,000 x g, and 400 µL of supernatant was removed leaving 100
µL for plating. Cell suspensions were then smeared on plates with antibiotics to select for the
transformed cells. Plating involved immersing the plate spreader (bent glass rod) into ethanol and
flaming for sterilization. The spreader was allowed to cool, and then cells were spread evenly
across the plate with making sure to use gentle contact with plate. Plates were then incubated at
37°C overnight with the cover-side down.
Starter cultures were formed either from plates or from glycerol stocks that were kept in
the -80°C freezer. If a glycerol stock was being used, then a sterile pipet tip was simply inserted
into the frozen stock and some of the stock would adhere to the tip. The tip would then be ejected
into a sterile conical flask with 15 mL of terrific broth. If the cells from the plates were being
used, then an inoculation loop was used to pick off a colony from the plate, and the rod could
then be submerged into the broth. The broth was always treated with antibiotics, specifically 15
µL of Chloramphenicol (CAM) and 15 µL of Kanamycin (KAN).
After 1 hour of incubation at optimal conditions, the starter culture was subcultured into
one liter flasks and brought down to an optical density (OD) at 600 nm of 0.02. Growth in the
one liter flasks was controlled in an incubator shaking at 250 rpm. When an OD600 of 1.2-1.5 was
reached, cells were cooled to 15°C for equilibration. After approximately one hour, OD600 would
reach 2-2.3 and expression could be induced. Induction was accomplished by adding 10 µL of
IPTG to each one liter flask. Cells were then left to incubate overnight at 15°C (approximately
16-18 hours) and were harvested the following morning. Cell harvest was completed by 30
minutes of centrifugation at 4°C and 10,000 x g,
followed by freezing of cell pellets at -80°C.
To make sure that PAI-1 expression was
being induced (Fig. 6), samples were analyzed by
sodium

dodecyl

electrophoresis

sulfate

polyacrylamide

(SDS-PAGE).

Proteins

gel
were
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Figure 6: Induction of PAI-1 protein
expression (image credit: REU student
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denatured by boiling with SDS and reducing
sample dye. Wells were loaded with ladder in
the first lane and samples in subsequent lanes,
and gels were run at 150 volts for 70 minutes.
Transfer

to

nitrocellulose

membrane

for

“Western blotting” was begun by placing the
Figure 7: Purified PAI-1 proteins analyzed
by SDS-PAGE and Western immunoblot.

gel and nitrocellulose sheet in between two
foam pieces wet with conductive transfer buffer

and running for 10 minutes at 15 volts. To block the membrane from nonspecific binding, it was
incubated for one hour at room temperature shaking in 10% milk. This was followed by addition
of primary antibody (usually rabbit antihuman PAI-1), and the membrane was allowed to
incubate for two hours. Then the secondary antibody was added (usually peroxidase labeled antirabbit), and the membrane was incubated for one hour shaking at room temperature. The
membrane was washed three times with phosphate buffered saline (PBS) containing Tween in
between blocking, primary antibody addition, and secondary antibody addition. To develop the
Western: 30 mL of 1x Pbs, 5 mL of 4-chloro-1-napthol, and 50 µL of 30% hydrogen peroxide
were added to the membrane. The partially-transferred gel was stained in Coomassie Blue and
then destained overnight.
The harvested cells were lysed (Fisher Scientific 550 Sonicator Dismembrator), and PAI1 was purified using an EDTA-free purification protocol that included Chelex-treated buffers.
The lysate was centrifuged at 10,000 x g for 30 min at 4°C. The supernatant was then loaded on
SP-Sepharose cation exchange column at 10 mL/min and flow thru was collected. Elution was
done by using a linear 80-500 mM (NH4)2SO4 gradient to gradually disrupt ionic interactions.
During the protein elution, we collected one minute fractions at 10 mL/min, and read the
absorbance at 280 nm (A280) fractions and plotted elution versus absorbance to make the elution
profile. The samples collected from supernatant, flow thru, and wash were analyzed by SDSPAGE and Western blot. The pool was then transferred to dialysis membrane tubing (molecular
weight cutoff 12-14,000 Da) and dialyzed against 4 L of imidazole buffer overnight at 4°C. The
next day IMAC was utilized by charging a Chelating Sepharose column with 0.2 M NiSO4
flowing long enough to allow nickel to bind the column, and excess nickel was removed with the
wash buffer. Dialyzed protein was loaded onto Ni2+ Sepharose column. Then we washed with
8
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imidazole buffer and applied an imidazole gradient to compete with histidine binding for release
of bound proteins. The fractions were read to create and elution profile, and we analyzed by
SDS-PAGE and Western blot. The protein was then concentrated to 2-3 milliliters volume and
loaded on S-100 filtration column for fraction collection overnight. This was followed by reading
fractions and making an elution profile. The PAI-1 peak fractions were pooled and 100 µL
aliquots were stored in -80°C freezer until use. Proteins were analyzed for purity by SDS-PAGE
and identity of PAI-1 proteins was confirmed by Western blot. Mutants were assayed for tPAbinding activity.
To measure protein concentration we used the bicinchoninic acid (BCA) protein assay.
We prepared the BCA Working Reagent (WR) by using a formulate to determine the total of
volume of WR needed in order to add 2 mL to each sample, and then preparing the WR by
mixing 50 parts of BCA Reagent A with 1 part of BCA Reagent B. We used the standard
protocol for the test-tube procedure. This begins with pipetting 0.1 mL of each standard and
unknown sample replicate to each tube, then adding 2.0 mL of the WR to each tube and mixing.
The tubes are then incubated at 37°C for 30 minutes in a water bath, and then cooled to room
temperature. Then we measured absorbance at 562 nm, and we were able to the make a standard
curve by plotting the measurements against concentration (µg/mL) after subtracting the
absorbance measurement of the blank.
To investigate metal binding to our protein and detect changes in affinity and enthalpy,
we used a technique called isothermal titration calorimetry (ITC). We ran our protein through a
desalting PD-10 column to remove any EDTA and phosphate. We began by running 40 mL of 50
mM MOPS, 100 mM (NH4)2SO4 buffer through the PD-10 column, and then we ran the protein
through the column in 2.5 mL of buffer. We then placed the protein in a dialysis cassette and
placed the cassette in the ITC buffer, and we allowed it to stir in the cold room overnight. After
extracting the protein solution and adding the metal to it, we made sure to keep our solution at a
pH of 7.4. We could now take it to the calorimeter. The calorimeter contains a reference cell and
an experimental cell, and we began by degassing all solutions and placing degassed deionized
water in the experimental cell. We rinsed the cell several times with water and then buffer, and
we added our ligand and protein solutions into the instrument. Finally, the experimental titration
was started and the data was collected at 10°C
9
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Using a PTI fluorometer, we tested the transmission of single Trp PAI-1 mutants W86Only, W139-Only, W175-Only, and W262-Only to the FRET donor Tb(III). With excitation slit
width set to 8 nm, emission scans were completed with the wavelength range of 310 to 360 nm
(range of FRET donor Trp) using a 2 nm slit width, and 520 to 570 nm (range of FRET acceptor
Tb) using a 12 nm slit width. Using quartz cuvettes we produced 2 mL solution with the
concentrations of 100 mM MOPS, 50 µM TbCl3, and a relevant concentration of the PAI-1
mutant. Before taking measurements, we inserted a glass panel between the sample and detector
to eliminate the transmission of excitation wavelength scattering. Our first measurement was
without Tb, followed by a zero time point with 50 µM Tb, followed by measurements at 5-10
minute intervals until 30 minutes were complete. With each mutant we obtained thirty minutes of
data for each of four increasing concentrations (250, 500, 750, 1000 nM) of protein.

Results and Discussion
These studies were conducted with the goal of obtaining more information about the
metal binding location within PAI-1 as reported by the four Trp sites shown in Fig. 5. To obtain
site-specific results, mutants were generated to isolate the spectral properties of each Trp residue.
Plasmids were successfully produced for each mutant such that the other three Trp sites were
genetically altered to encode Phe, leaving only a single Trp in the mutants known as W86-Only,
W139-Only, W175-Only, and W262-Only. We can see
positive mutant expression in Fig. 6 as indicated by the
bands by SDS-PAGE, and after protein purification the
identities were confirmed as PAI-1 by Western blot (Fig.
7). Using ITC we tested the mutant PAI-1 protein W262Only (Fig. 8) to confirm that mutagenesis did not alter
metal-binding properties. According to a one-site binding
fit of the data, the W262-Only PAI-1 protein (Kd ~ 10
nM) showed a modest increase in the apparent affinity for
copper relative to results obtained for wild-type PAI-1 (Kd
~ 22 nM). This may be within experimental variation for
Figure 8: ITC plot for W262-Only
PAI-1 titrating copper sulfate.

ITC measurements, especially given the sensitivity of the
technique to any change in protein concentration. Because
10
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the concentration of the Trp mutants cannot be reliably determined by spectrophotometric
absorbance at 280 nm due to differences in quantum yield among individual sites,6 they must be
BCA assayed for measurement accuracy. Since the protein solution was subjected to dialysis to
exactly match the buffer used for titrating copper, a slight dilution could have occurred that
would alter the numbers generated while fitting the ITC data points. Additionally, there is an
artifact in the ITC data (after the sigmoidal enthalpic shift) as the instrument overshot the
baseline while regaining temperature equilibrium, so a repeat measurement is warranted to verify
the result. Regardless of the specific details, the plot shows that the mutant binds copper, which
was the verifiable goal of the measurement.
Terbium has been used to map calcium
binding sites because of its similar ionic radius and
metal coordination chemistry.5 While transition
metals display variable physical features, it was
confirmed with stopped-flow fluorometry that the
conformational change reported by W262-Only
looks similar to the response evoked by zinc (data
not

shown).

Fluorescence

resonance

energy

transfer can be utilized to determine distance of the

Figure 9: Terbium fluorescence changes
with increasing concentration of W262-

transition metal binding site from individual Trp
sites in PAI-1 because of energy transfer from the aromatic residues to the bound terbium ions.
Signal differences among the four Trp sites can be used to elucidate the location of the transition
metal binding site. One caveat to this assertion is the aforementioned fact that each Trp residue
contributes a different amount of light, so the resulting changes in terbium fluorescence should
be viewed through this prism. As shown in Fig. 9, a 30 µM Tb(III) solution was used with
increasing W262-Only concentrations from 250 nM to 1000 nM. Excitation wavelength was set
to 295 nm to selectively activate Trp sites and avoid confounding data with Tyr signals. Each
data point in the figure is an average of the fluorescence measurements taken over 30 minutes.
The increase of fluorescence emission at 544 nm suggests that the metal is indeed binding to the
protein, with the nearby Trp residue transmitting light to increase the Tb signal. It is important to
note that the W262-Only site is the most buried from solvent within the core of the folded
protein, yet it exhibits the highest quantum yield of emitted light relative to the other three sites.
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For comparison, Fig. 10 shows
relative changes for all of the PAI-1
protein constructs after an hour-long
incubation with 50 µM Tb(III). At first
glance, the W262-Only mutant looks
most

interesting

as

the

protein

undergoing the biggest change in
fluorescence when more protein is
available
Figure 10: Linear changes in terbium fluorescence with
increasing concentration of PAI-1 protein constructs.

to

bind

the

terbium.

However, it is unclear whether this
trend will be upheld after data

correction to include provision for differences in quantum yield. For instance, the slope of the
W175-Only mutant data is comparable to that of the W262-Only mutant, and factoring in the
lower brightness of the W175 site, the overall trend may become more dramatic after correction
treatment. Interestingly, the W175 and W262 sites are located near the same “top” pole of the
protein close to the RCL, while the W139 site is located near the “bottom” pole within the SMB
domain and the highly solvent-exposed W86 site is situated in between the two extremes.
Perhaps this data is suggesting the metal binding site is close to the top end of PAI-1, but further
investigation will certainly be required to answer that hypothesis.

Conclusion
We effectively generated and investigated the W262-Only PAI-1 mutant using a
combination of techniques from molecular biology and protein biochemistry to isothermal
binding kinetics and intrinsic tryptophan fluorescence in order to better understand its metal
interaction properties. Our focus on the W262-Only mutant is only one piece of the puzzle;
however, more work remains to be completed in order to successfully elucidate the location of
the transition metal binding site on the PAI-1 structure. When further analysis is completed on
the other three mutants, more critical steps will have been taken toward the characterization of
the putative metal binding site within this important therapeutic target for inflammatory disease.
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